1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Glykon Technologies Group LLC currently has 1 pending office action. This action is being handled by examiner KOSACK, JOSEPH R, who is the busiest examiner for the portfolio with 1 pending matter. The prosecution is distributed across 1 distinct examiner and 1 distinct art unit.
The presence of 1 pending office action suggests a low volume of current activity at the patent office. Because KOSACK, JOSEPH R is the 1 examiner involved, the pending action represents the entirety of the portfolio's active office actions. The use of 1 distinct art unit indicates that the matter is concentrated within a single administrative division.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOSACK, JOSEPH R | 1 | 74.8% | -6.1% |
| Art Unit | Apps |
|---|---|
| 3991 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18235295 | Bolus Dose of Hydroxycitric Acid with Glycerol | KOSACK, JOSEPH R | 3991 | DP | Non-Final OA | — | Pending | Aug 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGlykon Technologies Group LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Joseph R Kosack has the most, with 1 of Glykon Technologies Group LLC's pending office actions.
